188 related articles for article (PubMed ID: 9804624)
1. Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor.
Williams BY; Dion SB; Schonbrunn A
Mol Pharmacol; 1998 Nov; 54(5):889-98. PubMed ID: 9804624
[TBL] [Abstract][Full Text] [Related]
2. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
Mantey S; Frucht H; Coy DH; Jensen RT
Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
[TBL] [Abstract][Full Text] [Related]
3. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
Reile H; Armatis PE; Schally AV
Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
[TBL] [Abstract][Full Text] [Related]
4. Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin receptor subtypes: a comparative study.
Wang LH; Mantey SA; Lin JT; Frucht H; Jensen RT
Biochim Biophys Acta; 1993 Jan; 1175(2):232-42. PubMed ID: 8380344
[TBL] [Abstract][Full Text] [Related]
5. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ligand binding and processing by bombesin receptors in an insulin-secreting cell line.
Swope SL; Schonbrunn A
Biochem J; 1987 Nov; 247(3):731-8. PubMed ID: 2827637
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
[TBL] [Abstract][Full Text] [Related]
8. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
9. Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites.
Williams BY; Wang Y; Schonbrunn A
Mol Pharmacol; 1996 Oct; 50(4):716-27. PubMed ID: 8863815
[TBL] [Abstract][Full Text] [Related]
10. Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.
Staley J; Coy DH; Jensen RT; Moody TW
J Mol Neurosci; 1993; 4(1):29-40. PubMed ID: 8391295
[TBL] [Abstract][Full Text] [Related]
11. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
Amiot F; Leiber D; Marc S; Harbon S
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
[TBL] [Abstract][Full Text] [Related]
12. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
13. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
Breeman WA; Hofland LJ; de Jong M; Bernard BF; Srinivasan A; Kwekkeboom DJ; Visser TJ; Krenning EP
Int J Cancer; 1999 May; 81(4):658-65. PubMed ID: 10225459
[TBL] [Abstract][Full Text] [Related]
15. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
16. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
17. Potent bombesin receptor antagonists distinguish receptor subtypes.
von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characteristics of bombesin receptor mediating hypothermia in the central nervous system of rats.
Tsushima H; Mori M; Fujiwara N; Moriyama A
Brain Res; 2003 Apr; 969(1-2):88-94. PubMed ID: 12676368
[TBL] [Abstract][Full Text] [Related]
19. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
Benya RV; Fathi Z; Kusui T; Pradhan T; Battey JF; Jensen RT
Mol Pharmacol; 1994 Aug; 46(2):235-45. PubMed ID: 8078487
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
Swope SL; Schonbrunn A
Mol Pharmacol; 1990 May; 37(5):758-66. PubMed ID: 2160064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
